Cargando…
Targeting Chemokine Receptor CCR1 as a Potential Therapeutic Approach for Multiple Myeloma
Multiple myeloma is an incurable plasma B-cell malignancy with 5-year survival rates approximately 10-30% lower than other hematologic cancers. Treatment options include combination chemotherapy followed by autologous stem cell transplantation. However, not all patients are eligible for autologous s...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991687/ https://www.ncbi.nlm.nih.gov/pubmed/35399952 http://dx.doi.org/10.3389/fendo.2022.846310 |